The KanaVape trial: what's at stake?
Next Monday sees the trial in Marseille of KanaVape, the first CBD-based electronic cigarette marketed in France in 2014.
Revolutionary at the time, the product was accused of being presented as a drug. The French Ministry of Health pushed hard to prohibit all marketing of the product in France, and to prosecute the two founders of KanaVape, Antonin Cohen and Sébastien Béguerie.
Antonin and Sébastien are not exactly strangers. One is now at the helm of Harmony, the recently launched featured on the front page of Le Parisien, the other markets cannabinoid test kits and CBD products under the brand name Alpha-Cat and is the co-founder of UFCM and co-organizer of the UFCM-I-Care conference in Strasbourg on the use of cannabinoids in medicine.
Both know their stuff, and have paved the way for all CBD e-liquids marketed in France today. So what will come out of this trial, even though the French Ministry of Health asserted this week in Le Parisien that these products are legal? We can't really answer that, or predict the outcome. But it goes without saying that we'll be following it closely.
Deliberation is scheduled for early 2018.
-
Business3 weeks ago
New York Opens Its Farmers' Markets to Small-Scale Cannabis Producers
-
Cannabis in France4 weeks ago
French Polynesia Is Finally Ready to Launch Its «Medical Cannabis» Pilot Program After Months of Delays
-
Cannabis in Nepal4 weeks ago
A Nepalese province legalizes medical cannabis
-
Cannabis in California4 weeks ago
Eight years after legalization, cannabis use in California has not increased
-
Cannabis in India3 weeks ago
India Approves a Synthetic CBD Drug for Anxiety
-
Cannabis in Africa3 weeks ago
Rwanda: A New License Revives the Country's Ambitions in Medical Cannabis
-
Cannabis in Europe3 weeks ago
The EU Simplifies Regulations Governing Hemp Cultivation
-
Cannabis in Canada4 weeks ago
Quick Hit July 2026: What We Missed in Recent Weeks


You must be logged in to post a comment Login